Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy
The four-component meningococcal serogroup B vaccine (4CMenB) contains antigens present in the majority of meningococci causing invasive meningococcal disease (IMD) and may potentially offer protection against strains belonging to non-B serogroups. This study aimed to evaluate the ability of 4CMenB-...
Saved in:
Main Authors: | Cecilia Fazio (Author), Alessia Biolchi (Author), Arianna Neri (Author), Sara Tomei (Author), Paola Vacca (Author), Luigina Ambrosio (Author), Annapina Palmieri (Author), Elena Mori (Author), Rita La Gaetana (Author), Mariagrazia Pizza (Author), Marzia Monica Giuliani (Author), Laura Serino (Author), Paola Stefanelli (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France
by: Eva Hong, et al.
Published: (2021) -
Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269
by: Maria Stella, et al.
Published: (2020) -
Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules
by: Alessia Biolchi, et al.
Published: (2019) -
Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB)
by: Adriana Efron, et al.
Published: (2023) -
4CMenB journey to the 10-year anniversary and beyond
by: Véronique Abitbol, et al.
Published: (2024)